IMR Press / CEOG / Volume 51 / Issue 1 / DOI: 10.31083/j.ceog5101011
Open Access Original Research
Cervical Stump Cancer after Subtotal Hysterectomy: A Retrospective Research of 127 Cases from China and Literature Review
Jia Wang1,2Xi Zeng1,3Lin Min1,3Lin Li1,3,*
Show Less
1 Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, 610041 Chengdu, Sichuan, China
2 Department of Gynecology Vip Nursing, West China Second University Hospital, West China School of Nursing, Sichuan University, 610041 Chengdu, Sichuan, China
3 Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, China
*Correspondence: lilin0119@scu.edu.cn (Lin Li)
Clin. Exp. Obstet. Gynecol. 2024, 51(1), 11; https://doi.org/10.31083/j.ceog5101011
Submitted: 9 July 2023 | Revised: 28 September 2023 | Accepted: 12 October 2023 | Published: 8 January 2024
Copyright: © 2024 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Background: Cervical stump cancer is a rare disease, which is subsequent to a previous subtotal hysterectomy. Among patients who underwent a subtotal hysterectomy, approximately 1%–3% develop cervical stump cancer which represents 3%–9% of all the cervical cancers. Methods: After acquiring consent from our ethics committee, we recruited the subjects and reviewed the patients’ data of those who were admitted to our hospital from January 2010 to December 2022. Written informed consent from all the study participants was acquired, and all materials complied with the Declaration of Helsinki and ethical standards. The patients’ data records, including clinical characteristics, treatment methods, human papillomavirus (HPV) infection conditions before the operation, complications of the treatment and follow-up status were analyzed. The HPV infection status was detected by Tellgen systems (Tellgen Corporation, Shanghai, China). SPSS software (Version 22.0, IBM Company, Armonk, NY, USA) was used for data analysis. Data is shown as mean ± standard deviation. A two-side p value < 0.05 was considered to be significant. Results: There were 127 cases with cervical stump cancer treated in our hospital during this period. The interval time between subtotal hysterectomy and stump cancer was 130.7 months. Vaginal bleeding, postcoital bleeding and pelvic pain were the main symptom. Seventy-two cases were squamous cancer and adenocarcinoma occurred in 39 cases. All patients received surgery or concurrent chemoradiotherapy. One hundred and ten cases were included in the follow-up. The median observation time was 65 months. Vaginal bleeding, gastrointestinal symptoms and vaginal contracture were the most common complications. The median observation time was 65 months and the 5-year disease-free rate for all patients was 51.8% with the 5-year overall survival for all patients being 77.3%. Conclusions: Subtotal hysterectomy results in a potential to develop cervical stump cancer. Cytological studies, cervical biopsy and endocervical curettage should be considered before a subtotal hysterectomy is performed. The patients should be well informed of the risk for retaining the cervical stump and further cervical stump cancer screening is mandatory.

Keywords
cervical stump cancer
subtotal hysterectomy
retrospective analysis
1. Introduction

Subtotal hysterectomy is a cervix-sparing hysterectomy, which was first performed by Manchester School of Medicine in 1843 [1]. Advocates hypothesized that the remaining cervix may help pelvic support, sexual response and urinary function as well as being associated with shorter operative time, decreased blood loss and less operative complications [2]. Thus, subtotal hysterectomy was routinely undertaken in China for benign gynecologic conditions in the past decades. Although total hysterectomy has taken the place of subtotal hysterectomy, there still remains a large number of women experienced a subtotal hysterectomy with retained cervical stump.

The first cervical stump cancer was reported in 1895 [3]. Among the patients receiving a subtotal hysterectomy, approximately 1%–3% will develop cervical stump cancer resulting in 3%–9% of all cervical cancers [4]. The mean age for the stump cancer patient was older when compared to those with cervical cancer, which may add to a poorer prognosis [5]. There was no difference in the long term prognosis for radiotherapy treated squamous cell carcinoma cervical stump cancer and other cervical carcinomas, however the prognosis for adenocarcinoma stump cancers was worse than those with an intact uterus [4, 6].

Although the incidence trend of cervical stump carcinoma has risen in recent years, clinical research is still insufficient. Thus, we present this retrospective analysis and review of the related literatures.

2. Materials and Methods

The study was reviewed and approved by the ethics committee of West China Second University Hospital, Sichuan University, China. All the patients were recruited following the receipt of written consent between January 2010 to December 2022; all procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the declaration of Helsinki. Inclusion criteria for patients included: (1) cervical biopsies diagnosed with cervical stump cancer by two pathologists; (2) benign gynecological diseases for previous subtotal hysterectomy. The stage of the tumor was classified by utilizing the International Federation of Gynecology and Obstetrics (FIGO) criteria (2018) for cervical cancer. The patients’ data records, including clinical characteristics, treatment methods, complications of the treatment and follow-up status were analyzed. The human papillomavirus (HPV) infection status was detected by Tellgen systems (Tellgen Corporation, Shanghai, China).

Written informed consent from all the study participants were acquired, and all subjects complied with the Declaration of Helsinki and ethical standards.

SPSS software (Version 22.0, IBM Company, Armonk, NY, USA) was used for data analysis. Data is shown as mean ± standard deviation. A two-side p value < 0.05 was considered to be significant.

3. Results

There were 127 cervical stump cancer patients received treatment in our hospital. The mean age of patients was 48.41 years, ranging from 33–63 years. There was a mean time of 10.89 years between subtotal hysterectomy and diagnosis of stump cancer (ranging from 0.8 to 27 years) (Table 1).

Table 1.Description characters of the patients.
Varies Cervical stump cancer
Age (years) 48.41 ± 7.69
Body mass index (BMI) (kg/m2) 24.48 ± 2.99
Age at sex debut (years) 20.06 ± 3.01
Sex partners 2.43 ± 0.79
Interval time between subtotal hysterectomy and diagnosis of stump cancer (years) 10.89 ± 6.31
Family history of cancer
Yes 39
No 88
HR-HPV infection condition when diagnosed with cervical stump cancer
Positive 115*
Negative 12

Notice: Data is shown as mean ± standard deviation (SD).

HR-HPV, High-risk human papillomavirus.

*Some cases infected with more than one subtype simultaneously.

3.1 Reasons for Previous Subtotal Hysterectomy

The reasons for previous subtotal hysterectomy were fibromyoma (82 cases, 64.6%), placental implantation or intrapartum hemorrhage (20 cases, 15.7%), adenomyosis (15 cases, 11.8%), atypical hyperplasia of endometrium (9 cases, 7.1%), and uterus rupture due to traffic accident (1 case, 0.8%).

3.2 Clinical Presentation

Vaginal bleeding and postcoital bleeding (93 cases, 73.2%), pelvic pain (17 cases, 13.4%), and abnormal cytology (17 cases, 13.4%) were the most common clinical symptoms. The median interval between the onset of symptoms and a diagnosis was 7.42 months. Twenty-two cases were diagnosed within 2 years of the subtotal hysterectomy.

3.3 HPV Screening and Histopathological Findings

After diagnosed with cervical stump cancer, all the patients received cervical human papillomavirus screening, the distributions with HPV types were in Fig. 1.

Fig. 1.

The distributions with HPV types. Notice: Some cases infected with more than one subtype sponteneaous. HPV, human papillomavirus.

Among the 127 stump cancer cases, 72 (57.5%) cases were squamous carcinoma (SCC), adenocarcinoma (AC) in 39 (30.7%) cases, adenosquamous carcinoma (ASC) in 11 (8.7%) cases, neuroendocrine (NE) in 3 (2.4%) cases and undefined type in 2 (1.6%) patient.

3.4 Stage

Among the 127 cases, 73 cases (57.5%) were in stage I, 45 (35.4%) were in stage II, 8 (6.3%) cases were in stage III, and 1 (0.8%) patient was in stage IV. The distribution of stage associated with pathology is presented in Table 2.

Table 2.Disease stage distribution of patients with cervical stump cancer.
Variate SCC AC ASC NE Others Total
Stage No. % No. % No. % No. % No. % No. %
I 38 29.9 22 17.3 8 6.3 3 2.4 2 1.6 73 57.5
II 28 22.0 14 11.0 3 2.4 0 0 0 0 45 35.4
III 5 3.9 3 2.4 0 0 0 0 0 0 8 6.3
IV 1 0.8 0 0 0 0 0 0 0 0 1 0.8
Total 72 56.6 39 30.7 11 8.7 3 2.4 2 1.6 127 100

SCC, squamous carcinoma; AC, adenocarcinoma; ASC, adenosquamous carcinoma; NE, neuroendocrine carcinoma.

3.5 Treatment

To our patients, the treatment methods for cervical stump cancer are the same as for cancer of cervix. Ninety-five cases in early stages received transvaginal trachelectomy or a radical trachelectomy and pelvic lymphadenectomy (either laparoscopic or laparotomic abdominal). The rest 32 cases in late stages received concurrent chemoradiotherapy. The details of the stump patients are in Table 3.

Table 3.The characteristics with surgery treatment (75 cases in stage I, 22 cases in stage II).
Variate Transvaginal trachelectomy (10 cases) Laparoscopic surgery (54 cases) Laparotomic abdominal surgery (33 cases) p
Age (years) 47.88 ± 8.65 48.32 ± 8.24 49.01 ± 7.93 0.572
Interval time between subtotal hysterectomy and diagnosis of stump cancer (years) 11.23 ± 4.71 10.01 ± 7.39 10.76 ± 6.05 0.464
Blood loss (mL) 202 ± 86 267 ± 126 525 ± 188 0.015
Surgery time (min) 128 ± 44 212 ± 63 279 ± 55 0.047
Stage
I 5 45 25 0.067
II 5 9 8
Lymph node metastasis
Yes 2 18 12 0.617
No 8 34 21
Lymph vascular space invasion
Yes 3 22 14 0.776
No 7 32 19
Resection margin of the vaginal involvement
Yes 1 5 3 0.996
No 9 49 30
Hospital stay (d) 5.77 ± 2.55 7.31 ± 3.33 8.59 ± 2.09 0.031
Urinary catheter removement (d) 14.66 ± 1.39 21.54 ± 2.32 21.98 ± 2.18 0.32
Residual urine volumes (mL) 66.76 ± 13.23 80.32 ± 15.63 73.87 ± 17.59 0.18
3.6 Follow-Up and Complications

Seventeen cases (stage I-9 cases, II-6 cases, III-2 cases, IV-0 cases) lost follow-up after discharging from our hospital and the rest 110 cases were included in the follow-up. The median observation time was 65 months (range 4–129 months). The 5-year disease-free rate for all patients was 51.8% (57 cases, stage I-35 cases, II-21 cases, III-1 case, IV-0) and the 5-year overall survival for all patients was 77.3% (85 cases, stage I-50 cases, II-32 cases, III-3 cases, IV-0), respectively. Poor histologic differentiation correlated with a decreased long-term progression-free survival. Cigarette addiction patients, and those receiving prolonged courses of external beam irradiation, had a trend toward a worse prognosis. Vaginal bleeding (31 cases), gastrointestinal symptoms (25 cases) and vaginal contracture (17 cases) were the most common complications.

4. Discussion

Although supracervical hysterectomy is being gradually abandoned, it is still performed in some remote areas with poor medical care in China [2]. Most patients in less developed areas lack regular follow-up screening for cervical cancer and seek medical help only after the appearance of clinical symptoms such as abnormal vaginal bleeding and vaginal discharge [2]. Thus, the cervical stump carcinoma was diagnosed late after the sub-total hysterectomy [2]. From current theory, cervical stump cancer can be classified as two types: the one arising after subtotal hysterectomy within 2 years and the one formulating de novo from the stump itself after 2 years of the subtotal hysterectomy [7]. The former one can be a pseudo syndrome, which the cancer may have been already existed without notice and left behind the subtotal hysterectomy. Some researchers suggested a minimum interval time of 2 years between subtotal hysterectomy and diagnosis of stump cancer is necessary to support a true cervical stump cancer [8]. As described, in our study the time elapsed between the subtotal hysterectomy and the diagnosis of cancer of the cervical stump was various from 0.8 to 27 years. Some cases diagnosed within 2 years after subtotal hysterectomy drew our attention because of the fact that patient must already have been presenting the tumor at the time of the surgery. Thus, a 2-year mini-mum interval between subtotal hysterectomy and diagnosis is required to establish a true diagnosis of carcinoma of the cervical stump.

The morbidity of stump cancer is varied from 0.2% to 3.0% [9, 10, 11, 12, 13]. Both of this study and previous literature presented that fibromyoma is the most common reason for the former operation [1]. Based on another research of our team, we found that younger patients preferred to subtotal hysterectomy to cope with benign gynecological diseases and paid lower attention to medical follow-up examines and younger females are usually more active in sex action with higher possibility of HPV infection [14].

Squamous cancer is the most common type in cervical cancer, accounting for about 75% and adenocarcinoma is the second place, accounting for about 20% [6]. HPV-16 is associated with cervical squamous cancer incidence and HPV-18 is associated with adenocarcinoma formulation [15]. In our research, the proportion of adenocarcinoma was 30.7% in cervical stump cancer, and the incidence of HPV-18 infection was higher than HPV-16, which possibly suggested the endocervical lesion maybe missed by the cervical cytology screening after the subtotal hysterectomy. The sensitivity of pap-test is about 40%, in order to elevate this rate, HPV-DNA molecular testing can be added and the combination reached a sensitivity about 90% [16]. By the way, neither HPV-DNA nor Pap-test can predict patients’ risk of progression. We suppose that prior to the subtotal hysterectomy, a cervical cancer and HPV screening may be in arranged.

Patients with stage II carcinoma were found most frequently [17]. Hellström et al. [6] studied 145 cases of cancer of the cervical stump from 1959 to 1987, also found the greatest frequency in that stage. Considering the time that elapses for a tumor to reach stage II is very long, leading to the suspicion that the patients that underwent subtotal hysterectomy were probably inadequately followed up with Pap smears after the surgery.

To those patients within stage I or IIb, surgery is the prior treatment method [17]. Because of the disturbed anatomy, adhesion formations by the former surgery, the stump operation can be more difficult. Comparing with laparotomy, laparoscopy provides more clearly identify the ureter, and fewer injuries occur during the operation, a shorter recovery time and hospital stay, and fewer postoperative complications because it is a minimally invasive surgical operation [18].

To late stages, an individualized and comprehensive concurrent chemoradiotherapy is recommended. Intra-cervical radiotherapy may be hampered by the shorter cervical canal. After radiotherapy, high rate of complications has been reported [10, 19, 20]. Based on our study, the changed anatomy lead to more challenge in choosing the position of radiation target and dose distributions, which may answer to the poorer prognosis and complication. The prognosis of stump cancer in early is similar to cervical cancer; while, it is worse in stage III and IV compared with cervical cancer in the same stages [21].

Higher complication rates have been reported by other authors after radiotherapy [20]. In our cases, the patients treated by radiotherapy suffered no severe complications. Furthermore, in relation to radiotherapy, it seems that the changed anatomy after subtotal hysterectomy causes limitations on the delivery of appropriate radiation doses, which may be responsible for the poorer prognosis [9].

Limitations

This research analyzed clinical characteristics to arouse attention to the rare disease of cervical stump cancer. However, due to the cases are limited, we did not have a further Hierarchical analysis.

5. Conclusions and Highlighted Content

The frequency of cervical stump cancer is low, it should be well considered when deciding between supra-vaginal and total hysterectomy and the patients should be well informed the risk for retaining the cervical stump and further cervical stump cancer screening is mandatory. Cervical cytological screening, biopsy and endocervical curettage should be taken before a subtotal hysterectomy.

Availability of Data and Materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Author Contributions

JW: Project development, data collection and management, statistical analysis, manuscript writing; XZ: Data collection and management, statistical analysis, manuscript writing, submitting the manuscript; LM: Design of the work, obtaining funding, critical revision of the manuscript, manuscript writing, supervision; LL: Project development, statistical analysis, critical revision of the manuscript, supervision. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

The study was reviewed and approved by the ethics committee of West China Second University Hospital (No.2020-036), Sichuan University, China. All the patients were recruited following the receipt of written consent.

Acknowledgment

Not applicable.

Funding

This study was funded by the Science and Technology Department of Sichuan Province, China (2022YFS0081).

Conflict of Interest

The authors declare no conflict of interest.

References
[1]
Thom CH, Dunne TJ, Livornese G. Vaginal cervicectomy. Obstetrics and Gynecology. 1967; 30: 473–480.
[2]
Lu Z, Guo C, Wang T, Qiu J, Hua K. Characteristics, complications, and outcomes of early-stage cervical stump carcinoma: laparoscopy versus laparotomy. The Journal of International Medical Research. 2021; 49: 300060521992247.
[3]
DECKER DG, HUNT AB, FRICKE RE, NELSON GA. Carcinoma of the cervical stump. American Journal of Obstetrics and Gynecology. 1957; 73: 974–984.
[4]
Hellström AC, Sigurjonson T, Pettersson F. Carcinoma of the cervical stump. The radiumhemmet series 1959-1987. Treatment and prognosis. Acta Obstetricia et Gynecologica Scandinavica. 2001; 80: 152–157.
[5]
ZHAO X, YIN K, LI G. Progress in the treatment and prognosis of patients with cervical stump cancer. Journal of Chinese Physician. 2019; 1599–1600.
[6]
Hellström AC, Hellman K, Pettersson BF, Andersson S. Carcinoma of the cervical stump: fifty years of experience. Oncology Reports. 2011; 25: 1651–1654.
[7]
Shen Z, Zhou Y, Cheng Y, Li M, Wu D. Retrospective analysis of surgery for cervical stump carcinoma at early stage. Molecular and Clinical Oncology. 2018; 8: 352–355.
[8]
Calais G, Le Floch O, Chauvet B, Reynaud-Bougnoux A, Bougnoux P. Carcinoma of the uterine cervix stage IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 1989; 17: 1231–1235.
[9]
Hannoun-Lévi JM, Peiffert D, Hoffstetter S, Luporsi E, Bey P, Pernot M. Carcinoma of the cervical stump: retrospective analysis of 77 cases. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology. 1997; 43: 147–153.
[10]
Silva CS, Cardoso CO, Menegaz RA, Adad SJ, Angotti LFR, Murta EFC. Cervical stump cancer: a study of 14 cases. Archives of Gynecology and Obstetrics. 2004; 270: 126–128.
[11]
Wolff JP, Lacour J, Chassagne D, Berend M. Cancer of the cervical stump. Study of 173 patients. Obstetrics and Gynecology. 1972; 39: 10–16.
[12]
Petersen LK, Mamsen A, Jakobsen A. Carcinoma of the cervical stump. Gynecologic Oncology. 1992; 46: 199–202.
[13]
Dogan NU, Gungor T, Sahin I, Karsli F. Cancer of cervical stump diagnosed in a woman with chronic myelogenous leukaemia. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology. 2013; 33: 428–429.
[14]
Roenneburg ML. Cervical Stump Extirpation. Hysterectomy: A Comprehensive Surgical Approach. 2018; 1101–1105.
[15]
Chen W, Sun H, Molijn A, Zeng L, Kang L, Jenkins D, et al. The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China. Journal of Lower Genital Tract Disease. 2018; 22: 355–361.
[16]
D’Augè TG, Giannini A, Bogani G, Di Dio C, Laganà AS, Di Donato V, et al. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives. Clinical and Experimental Obstetrics & Gynecology. 2023; 50: 160.
[17]
Giannini A, Golia D’Augè T, Bogani G, Laganà AS, Chiantera V, Vizza E, et al. Uterine sarcomas: A critical review of the literature. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2023; 287: 166–170.
[18]
Giannini A, D’Oria O, Chiantera V, Margioula-Siarkou C, Di Donna MC, Terzic S, et al. Minimally Invasive Surgery for Cervical Cancer: Should We Look beyond Squamous Cell Carcinoma? Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research. 2022; 35: 1602–1603.
[19]
Miller BE, Copeland LJ, Hamberger AD, Gershenson DM, Saul PB, Herson J, et al. Carcinoma of the cervical stump. Gynecologic Oncology. 1984; 18: 100–108.
[20]
Okada K, Oike T, Ando K, Kubo N, Ohno T. Cervical Stump Cancer Treated With Radiotherapy Using Computed Tomography-Guided Brachytherapy. Cureus. 2021; 13: e13789.
[21]
Neis F, Reisenauer C, Kraemer B, Wagner P, Brucker S. Retrospective analysis of secondary resection of the cervical stump after subtotal hysterectomy: why and when? Archives of Gynecology and Obstetrics. 2021; 304: 1519–1526.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top